Global Cord Blood Corporation (CO) Tops Q2 EPS by 1c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Global Cord Blood Corporation (CO) Tops Q2 EPS by 1c, Revenues Beat

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020

November 26, 2019 4:16 PM EST

HONG KONG, Nov. 26, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the second quarter and first half of fiscal year 2020 ended September 30, 2019.

Second Quarter of Fiscal 2020 Highlights

Revenues increased by 26.9% year over year ("YoY") to RMB313.5 million ($43.9 million). New subscribers and accumulated subscriber base were 21,551 and 791,812[1], respectively. Gross profit increased by 32.7% YoY to RMB265.1 million ($37.1... More